Indegene's share price soared after Axis Direct initiated coverage with a 'buy' recommendation, suggesting an 18% upside. The company's blend of biopharma expertise and AI solutions positions it well for future growth, as per the brokerage firm. 
Indegene's share price soared after Axis Direct initiated coverage with a 'buy' recommendation, suggesting an 18% upside. The company's blend of biopharma expertise and AI solutions positions it well for future growth, as per the brokerage firm. 
<iframe src="https://hindustansphere.com/embed/cluster/3585c6e29f37585a327597ae14823757834caafa" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Indegene share price jumps 5% to hit a 52-week high after Axis initiates coverage with a buy - Check target price"></iframe>
